Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

18. SHARE CAPITAL (Details)

v3.21.2
18. SHARE CAPITAL (Details) - CAD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Issuance of share capital, net [1] $ 22,241,753 $ 26,299,820
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Monte Carlo simulation valuation model  
Shares issued debt settlement, Value [1] $ 5,848,000  
Share-based compensation [1] $ 3,955,976 $ 3,796,095
Fair value of the common share purchase warrants    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Monte Carlo valuation model  
Fair value of the compensation warrants    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used both Black-Scholes and Monte Carlo valuation models  
Options granted during the year    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Black-Scholes option pricing model  
Warants - 2    
Number Outstanding   2,001,000
Exercise Price $ 0.75  
Options granted #1    
Options Grant Date Jan. 11, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 171,429  
Exercise Price $ 1.00  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Jan. 11, 2025  
Options granted #2    
Options Grant Date Jan. 11, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 200,000  
Exercise Price $ 1.00  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Jan. 11, 2025  
Options granted #3    
Options Grant Date Apr. 01, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 161,250  
Exercise Price $ 1.00  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Apr. 01, 2025  
Options granted #4    
Options Grant Date Jul. 06, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 50,000  
Exercise Price $ 0.90  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Jul. 06, 2025  
Options granted #5    
Options Grant Date Jul. 27, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 50,000  
Exercise Price $ 1.00  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Jul. 27, 2025  
Options granted #6    
Options Grant Date Aug. 11, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 100,000  
Exercise Price $ 0.60  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Aug. 11, 2025  
Options granted #7    
Options Grant Date Sep. 08, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 250,000  
Exercise Price $ 0.66  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Sep. 08, 2025  
Options granted #8    
Options Grant Date Sep. 10, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 15,000  
Exercise Price $ 0.66  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Sep. 10, 2025  
Options granted #9    
Options Grant Date Oct. 01, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3,400,000  
Exercise Price $ 0.65  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Oct. 01, 2025  
Options granted #10    
Options Grant Date Oct. 01, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 800,000  
Exercise Price $ 0.65  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Oct. 01, 2025  
Options granted #11    
Options Grant Date Oct. 12, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 50,000  
Exercise Price $ 0.65  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Oct. 01, 2025  
Options granted #12    
Options Grant Date Nov. 18, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 350,000  
Exercise Price $ 0.67  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Nov. 14, 2025  
Options granted #13    
Options Grant Date Nov. 18, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 185,000  
Exercise Price $ 0.67  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Nov. 18, 2025  
Options granted #14    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 75,000  
Exercise Price $ 0.60  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Nov. 06, 2025  
Options granted #15    
Options Grant Date Dec. 03, 2020  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 800,000  
Exercise Price $ 0.75  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Dec. 03, 2025  
Common Stock    
Shares issued for bought deal, Shares [1] 33,350,000  
Shares issued debt settlement, Value [1] $ 2,292,416  
Stock Issued During Period, Shares, Acquisitions [2] 17,133,600  
Deemed shares issued, Shares [3] 23,464,462  
Stock Issued During Period, Shares, Issued for Services [3] 7,381,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures [1] 0 0
Convertible Series II Preferred    
Shares issued for bought deal, Shares [1]  
Shares issued debt settlement, Value [1] $ 3,555,584  
Stock Issued During Period, Shares, Acquisitions [2] 17,133,600  
Deemed shares issued, Shares [3] 0  
Stock Issued During Period, Shares, Issued for Services [3] 7,381,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures [1] 0 0
Private Placement #1    
Sale of Stock, Transaction Date Sep. 24, 2020  
Sale of Stock, Description of Transaction Company closed the bought deal offering for a total issuance of 33,350,000 units of the Company at a price of $0.75 per unit for aggregate gross proceeds of $25,012,500  
Private Placement #2    
Sale of Stock, Description of Transaction Company issued 1,411,333 units to settle a debt of $1,058,500, of which 866,666 units were issued to the CEO of the Company  
Debt Settlement #1    
Sale of Stock, Description of Transaction Company issued 2,339,200 units consisting of one common share and one series II preferred shares to a third-party to pay for $5,848,000 owed by PharmaCo to its related party  
Common Shares #1    
Sale of Stock, Transaction Date [4] Jan. 10, 2020  
Sale of Stock, Description of Transaction [4] Company issued rights to receive 17,133,600 common shares of MichiCann to sellers of MAG  
Common Shares #2    
Sale of Stock, Transaction Date Apr. 24, 2020  
Sale of Stock, Description of Transaction [3] Company issued 23,464,462 common shares to holders of Tidal common shares  
Common Shares #3    
Sale of Stock, Transaction Date [3] Apr. 24, 2020  
Sale of Stock, Description of Transaction [3] Company issued 7,381,000 common shares to related parties  
Common Shares #4    
Sale of Stock, Transaction Date Apr. 30, 2020  
Sale of Stock, Description of Transaction Company issued 429,375 common shares pursuant to the exercise of 429,375 warrants for gross proceeds of $343,500  
Common Shares #5    
Sale of Stock, Transaction Date May 25, 2020  
Sale of Stock, Description of Transaction Company issued 187,500 common shares pursuant to the exercise of 187,500 warrants for gross proceeds of $150,000  
Common Shares #6    
Sale of Stock, Transaction Date Jun. 08, 2020  
Sale of Stock, Description of Transaction Company issued 975,000 of common shares and 975,000 convertible series II preferred shares pursuant to the exercise of 975,000 stock options for gross proceeds of $487,500  
Common Shares #7    
Sale of Stock, Transaction Date [2] Jun. 10, 2020  
Sale of Stock, Description of Transaction [2] Company issued 13,500,000 common shares pursuant to High Times Licensing Agreement  
Common Shares #8    
Sale of Stock, Transaction Date [2] Jun. 10, 2020  
Sale of Stock, Description of Transaction [2] Company issued 1,800,000 common shares to finde  
Common Shares #9    
Sale of Stock, Transaction Date [5] Jun. 30, 2020  
Sale of Stock, Description of Transaction [5] Company issued 2,339,200 units consisting of one common share and one series II preferred share  
Common Shares #10    
Sale of Stock, Transaction Date Aug. 13, 2020  
Sale of Stock, Description of Transaction Company issued 500,000 common shares and 500,000 convertible series II preferred shares  
Common Shares #11    
Sale of Stock, Transaction Date Sep. 24, 2020  
Sale of Stock, Description of Transaction Company issued 500,000 common shares pursuant to transaction cost for $10,000,000 convertible debenture  
Common Shares #12    
Sale of Stock, Transaction Date Nov. 25, 2020  
Sale of Stock, Description of Transaction Company issued 6,000 common shares and 6,000 convertible series II preferred shares  
Common Shares #13    
Sale of Stock, Transaction Date Dec. 02, 2020  
Sale of Stock, Description of Transaction Company issued 47,910 common shares and 47,910 convertible series II preferred shares  
Common Shares #14    
Sale of Stock, Transaction Date Dec. 03, 2020  
Sale of Stock, Description of Transaction Company issued 175,000 common shares and 175,000 convertible series II preferred shares  
Common Shares #15    
Sale of Stock, Transaction Date Dec. 08, 2020  
Sale of Stock, Description of Transaction Company issued 400,000 common shares and 400,000 convertible series II preferred shares  
Common Shares #16    
Sale of Stock, Transaction Date Dec. 15, 2020  
Sale of Stock, Description of Transaction Company issued 4,500,000 common shares pursuant to the exercise of warrants  
Common Shares #17    
Sale of Stock, Transaction Date Dec. 17, 2020  
Sale of Stock, Description of Transaction Company issued 416,430 common shares and 416,430 convertible series II preferred shares pursuant to the exercise of warrants for gross proceeds of $416,430  
Convertible Series I Preferred Shares #1    
Sale of Stock, Transaction Date [3] Apr. 24, 2020  
Sale of Stock, Description of Transaction [3] Company issued 3,181,250 convertible series I preferred shares to Tidal shareholders  
Convertible Series II Preferred Shares #1    
Sale of Stock, Transaction Date [3] Apr. 24, 2020  
Sale of Stock, Description of Transaction [3] Company issued 101,345,349 to holders of MichiCann convertible series II preferred shares pursuant to Amended Agreement of the reverse takeover transaction  
Convertible Series II Preferred Shares #2    
Sale of Stock, Transaction Date [2] Apr. 24, 2020  
Sale of Stock, Description of Transaction [2] Company issued 17,133,600 to sellers of MAG convertible series II preferred shares pursuant to MAG acquisition  
Convertible Series II Preferred Shares #3    
Sale of Stock, Transaction Date [3] Apr. 24, 2020  
Sale of Stock, Description of Transaction [3] Company issued 7,381,000 convertible series II preferred shares to related parties  
Warrants #1    
Sale of Stock, Transaction Date Dec. 19, 2018  
Sale of Stock, Description of Transaction MichiCann issued 595,340 finders' warrants  
Warrants #2    
Sale of Stock, Transaction Date Apr. 24, 2020  
Sale of Stock, Description of Transaction Company issued 862,813 warrants to holders of Tidal warrants  
Warrants #3    
Sale of Stock, Transaction Date Apr. 24, 2020  
Sale of Stock, Description of Transaction Company issued 323,898 warrants towards finder's fee  
Warrants #4    
Sale of Stock, Transaction Date Jun. 10, 2020  
Sale of Stock, Description of Transaction Company issued 4,500,000 special warrants related to the 1251881 B.C. Ltd. acquisition  
Warrants #5    
Sale of Stock, Transaction Date Sep. 24, 2020  
Sale of Stock, Description of Transaction Company issued 33,350,000 warrants pursuant to bought deal financing agreement  
Warrants #6    
Sale of Stock, Transaction Date Sep. 24, 2020  
Sale of Stock, Description of Transaction Company issued 2,001,000 warrants to finders pursuant to bought deal financing agreement  
Options #1    
Sale of Stock, Transaction Date Jul. 27, 2020  
Sale of Stock, Description of Transaction Company adopted a rolling stock option plan  
[1] Note 18.
[2] Note 6.
[3] Note 5.
[4] Notes 5, 6.
[5] Note 11(b).